Skip to Main Content

An official website of the United States government

View 0 Studies Requested

Trial Summary

About CDAS Project, PI, Publications: Evaluation of a four kallekrein panel to detect prostate cancer

Datasets


Site: Prostate

Inclusion Criteria:

  • No Rare Cancers
  • No Prior History of Any Cancer
  • No Biopsies Prior to Randomization
  • Has Biopsy
  • Has PSA >= 4 During Biopsy Year
  • Age at PSA <= 75
  • No Uknown Gleason in Cases
  • Has Any Serum Available
  • Has Serum Available in Same Year as PSA (Eligible)
  • 1000 Selected at Random Proportional to Eligibles (Selected)

Match Ratio: Proportional to Eligibles

Match Technique: N/A

Additional Matching Comments: No true match, only selection of 1000 random subjects targeting African Americans first.


Analytes:

  • Beta-Microseminoprotein
  • Free PSA
  • Prostate Specific Antigen Inactive
  • Total Human Glandular Kallikrein-2
  • Total PSA

Number of Cases: 341

Number of Controls: 659